Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Liabilities and Shareholders Equity (2017 - 2025)

Catheter Precision has reported Liabilities and Shareholders Equity over the past 9 years, most recently at $15.9 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 42.89% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $91.7 million through Dec 2025, down 15.72% year-over-year, with the annual reading at $15.9 million for FY2025, 42.89% down from the prior year.
  • Liabilities and Shareholders Equity was $15.9 million for Q4 2025 at Catheter Precision, down from $25.5 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $48.5 million in Q1 2023 and troughed at $15.9 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $26.3 million (2024), against an average of $26.8 million.
  • Year-over-year, Liabilities and Shareholders Equity surged 104.27% in 2023 and then crashed 42.89% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $21.0 million in 2021, then decreased by 20.0% to $16.8 million in 2022, then soared by 82.56% to $30.7 million in 2023, then decreased by 9.65% to $27.8 million in 2024, then tumbled by 42.89% to $15.9 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Liabilities and Shareholders Equity are $15.9 million (Q4 2025), $25.5 million (Q3 2025), and $25.6 million (Q2 2025).